These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 11067978)
1. Cannabinoid and kappa opioid receptors reduce potassium K current via activation of G(s) proteins in cultured hippocampal neurons. Hampson RE; Mu J; Deadwyler SA J Neurophysiol; 2000 Nov; 84(5):2356-64. PubMed ID: 11067978 [TBL] [Abstract][Full Text] [Related]
2. Protein kinase-dependent phosphorylation and cannabinoid receptor modulation of potassium A current (IA) in cultured rat hippocampal neurons. Mu J; Zhuang SY; Hampson RE; Deadwyler SA Pflugers Arch; 2000 Mar; 439(5):541-6. PubMed ID: 10764212 [TBL] [Abstract][Full Text] [Related]
3. Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes. Sagan S; Venance L; Torrens Y; Cordier J; Glowinski J; Giaume C Eur J Neurosci; 1999 Feb; 11(2):691-9. PubMed ID: 10051770 [TBL] [Abstract][Full Text] [Related]
4. Cannabinoid CB1 receptor-mediated inhibition of acetylcholine release in the brain of NMRI, CD-1 and C57BL/6J mice. Kathmann M; Weber B; Schlicker E Naunyn Schmiedebergs Arch Pharmacol; 2001 Jan; 363(1):50-6. PubMed ID: 11191836 [TBL] [Abstract][Full Text] [Related]
5. Cannabinoid receptor activation in CA1 pyramidal cells in adult rat hippocampus. Kirby MT; Hampson RE; Deadwyler SA Brain Res; 2000 Apr; 863(1-2):120-31. PubMed ID: 10773200 [TBL] [Abstract][Full Text] [Related]
6. Effects of cannabinoid receptor ligands on electrophysiological properties of myenteric neurones of the guinea-pig ileum. López-Redondo F; Lees GM; Pertwee RG Br J Pharmacol; 1997 Sep; 122(2):330-4. PubMed ID: 9313943 [TBL] [Abstract][Full Text] [Related]
7. Cannabinoid receptors differentially modulate potassium A and D currents in hippocampal neurons in culture. Mu J; Zhuang SY; Kirby MT; Hampson RE; Deadwyler SA J Pharmacol Exp Ther; 1999 Nov; 291(2):893-902. PubMed ID: 10525114 [TBL] [Abstract][Full Text] [Related]
8. Cannabinoid receptor modulation of synapses received by cerebellar Purkinje cells. Takahashi KA; Linden DJ J Neurophysiol; 2000 Mar; 83(3):1167-80. PubMed ID: 10712447 [TBL] [Abstract][Full Text] [Related]
9. The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins. Lauckner JE; Hille B; Mackie K Proc Natl Acad Sci U S A; 2005 Dec; 102(52):19144-9. PubMed ID: 16365309 [TBL] [Abstract][Full Text] [Related]
10. Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons. Huang CC; Lo SW; Hsu KS J Physiol; 2001 May; 532(Pt 3):731-48. PubMed ID: 11313442 [TBL] [Abstract][Full Text] [Related]
11. Suppression of outward K⁺ currents by WIN55212-2 in rat retinal ganglion cells is independent of CB1/CB2 receptors. Zhang CQ; Wu HJ; Wang SY; Yin S; Lu XJ; Miao Y; Wang XH; Yang XL; Wang Z Neuroscience; 2013 Dec; 253():183-93. PubMed ID: 24013008 [TBL] [Abstract][Full Text] [Related]
12. Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist, SR 141716A. Gifford AN; Ashby CR J Pharmacol Exp Ther; 1996 Jun; 277(3):1431-6. PubMed ID: 8667207 [TBL] [Abstract][Full Text] [Related]
13. Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices. Ameri A; Wilhelm A; Simmet T Br J Pharmacol; 1999 Apr; 126(8):1831-9. PubMed ID: 10372827 [TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of cannabinoid agonists on gastric emptying in the rat. Izzo AA; Mascolo N; Capasso R; Germanò MP; De Pasquale R; Capasso F Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):221-3. PubMed ID: 10494894 [TBL] [Abstract][Full Text] [Related]
15. SR141716A is an inverse agonist at the human cannabinoid CB1 receptor. Landsman RS; Burkey TH; Consroe P; Roeske WR; Yamamura HI Eur J Pharmacol; 1997 Sep; 334(1):R1-2. PubMed ID: 9346339 [TBL] [Abstract][Full Text] [Related]
16. Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus. Coutts AA; Pertwee RG Br J Pharmacol; 1997 Aug; 121(8):1557-66. PubMed ID: 9283688 [TBL] [Abstract][Full Text] [Related]
17. The cannabinoid CB1 receptor mediates retrograde signals for depolarization-induced suppression of inhibition in cerebellar Purkinje cells. Yoshida T; Hashimoto K; Zimmer A; Maejima T; Araishi K; Kano M J Neurosci; 2002 Mar; 22(5):1690-7. PubMed ID: 11880498 [TBL] [Abstract][Full Text] [Related]
18. Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats. Fattore L; Cossu G; Martellotta CM; Fratta W Psychopharmacology (Berl); 2001 Aug; 156(4):410-6. PubMed ID: 11498718 [TBL] [Abstract][Full Text] [Related]
19. The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats. Izzo AA; Mascolo N; Pinto L; Capasso R; Capasso F Eur J Pharmacol; 1999 Nov; 384(1):37-42. PubMed ID: 10611417 [TBL] [Abstract][Full Text] [Related]
20. Activation of brain-type cannabinoid receptors interferes with preimplantation mouse embryo development. Yang ZM; Paria BC; Dey SK Biol Reprod; 1996 Oct; 55(4):756-61. PubMed ID: 8879486 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]